This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Mediwound (MDWD)

Tipranks - Tipranks - Wed Jun 3, 10:20AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Moderna (MRNA) and Mediwound (MDWD).

Claim 55% Off TipRanks

Moderna (MRNA)

In a report released today, Michael Yee from UBS maintained a Hold rating on Moderna, with a price target of $45.00. The company’s shares closed last Tuesday at $44.90, close to its 52-week low of $29.25.

According to TipRanks.com, Yee is a 2-star analyst with an average return of 0.4% and a 43.5% success rate. Yee covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, ALX Oncology Holdings, and Bristol-Myers Squibb. ;'>

Currently, the analyst consensus on Moderna is a Hold with an average price target of $44.35, which is a -2.2% downside from current levels. In a report issued on May 22, William Blair also maintained a Hold rating on the stock.

See today’s best-performing stocks on TipRanks >>

Mediwound (MDWD)

In a report released yesterday, Michael Okunewitch from Maxim Group maintained a Buy rating on Mediwound, with a price target of $30.00. The company’s shares closed last Tuesday at $13.68, close to its 52-week low of $12.78.

According to TipRanks.com, Okunewitch is a 1-star analyst with an average return of -1.6% and a 39.6% success rate. Okunewitch covers the Healthcare sector, focusing on stocks such as Radiopharm Theranostics Limited Sponsored ADR, Rani Therapeutics Holdings, and Acrivon Therapeutics, Inc. ;'>

Mediwound has an analyst consensus of Strong Buy, with a price target consensus of $29.00, implying a 107.9% upside from current levels. In a report issued on May 28, Oppenheimer also maintained a Buy rating on the stock with a $32.00 price target.

Read More on MRNA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).